Contractor profile

Exelan Pharmaceuticals Inc

FY2026 ended Sep 30 · data still posting · data as of 2026-11-01†

† DoD contract data posts to USAspending about 90 days after award.

prime recipient of federal awards · UEI FYZXNHSQTMG8 Source
$96.2M
Obligated
FY2026 · data still posting
3
Funding agencies
100%
From Veterans Affai…
0%
Non-competed
6
States
82%
In Florida
2
Industries

In FY2026, Exelan Pharmaceuticals Inc received $96.2M in federal awards from 3 agencies, 100% of it from the Department of Veterans Affairs, with 82% of the work performed in Florida. FY2026 ended Sep 30 and its data is still posting. Computed

Where this money comes from

Source
Department of Veterans Affairs$96.1M
Department of Justice$31.8K

Where the work lands

Source
Florida$79.3M
North Carolina$8.3M
Iowa$2.9M
North Dakota$1.2M
Minnesota$550K
New Jersey$1.7K

State breakdown available for 95% of obligations shown

Key takeaways

Computed
FY2026 ended Sep 30 · data still posting · data as of 2026-11-01
  • Exelan Pharmaceuticals Inc received $96.2M in federal obligations in FY2026 (data still posting).
  • The Department of Veterans Affairs accounted for 99% of it.
  • Its largest recorded industry was Pharmaceutical Preparation Manufacturing, at $96.2M.
  • Florida was its largest place of performance, with 82% of the work.

Awards

Source

Largest active awards by total value

Awards whose period of performance overlaps FY2026, by the amount obligated on each so far.

No award on record was active in FY2026.

Largest FY2026 awards

Awards that started in FY2026, by the amount obligated on each so far.

No award on record started in FY2026.

What it does (NAICS / PSC)

Pharmaceutical Preparation Manufacturing$96.2M

Competition

0%non-competed (often called no-bid), of $96.2M in contract obligations in FY2026Computed

This describes how contracts were awarded, not wrongdoing.

Similar federal contractors

Computed
Mckesson Corporation$14.9B
Merck Sharp & Dohme LLC$2.3B
Pfizer Inc$1.1B
Glaxosmithkline, LLC$1.1B
Sanofi Vaccines US Inc.$734.4M
Emergent Biosolutions Canada Inc$118.3M
Canadian Commercial Corporation$16.4M
Trillamed LLC$1.1M

Corporate family

Single registration: no combined family.

Related

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.